email   Email Us: phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2643-6760

Surgery & Case Studies: Open Access Journal

Opinion(ISSN: 2643-6760)

Double Malignancies: A Rare Entity

Volume 1 - Issue 1

Subhashish Das*

  • Author Information Open or Close
    • MD, Professor of Pathology, Sri Devaraj Urs Medical College, Inida

    *Corresponding author: Subhashish Das, Department of Pathology, Sri Devaraj Urs Medical College, Sri Devaraj Urs University, Tamaka, Kolar, India

Received: April 30, 2018;   Published: May 03, 2018

DOI: 10.32474/SCSOAJ.2018.01.000104

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


Patients which have diagnosed with a cancer, have a life time risk for developing another de novo malignancy depending on various inherited environmental and iatrogenic risk factors. Cancer victims could survive longer due to settling treatment modalities, and then would likely develop a new metachronous malignancy [1]. The incidence of multiple primary malignancies has not been rare at all. Screening procedures have especially been useful for the early detection of associated tumors, whereas careful monitoring of patients has treated for primary cancer, and then a good communication between patients and medical care team would certify not only an early detection for secondary tumors, but only finally & subsequently, an appropriate management [2].

Abbreviations: MPM: Multiple Primary Malignancies; SEER: Surveillance Epidemiology and End Results Programme; SPT: Second Primary Tumor; TT: Third Tumor; QT: Quadrant Tumor; SPM: Second Primary Malignancies; NAACCR: North American Association of Central Cancer Registries

Introduction| Conclusion| References|